Article Figures & Tables
Figures
- Fig. 1.
Stomach hyperplasia in mutant mice. (A) Macroscopic external (left) and internal (right) images of WT, KI/+ and KI/KI stomachs. Images are representative examples of stomachs from mice at birth (top) and more than 1 year old (bottom). Scale bar: 1 cm. (B) Gastric antrum thickness (μm) over time. (C) Gastric corpus thickness (μm) over time. (D) Stomach mass index (weight of the stomach normalized by the total weight of the animal) over time. (E) Size index (size of the stomach normalized by the total weight of the animal) over time. n=6 per genotype. ns, not significant. Data in B-E are represented as mean±s.d.
- Fig. 2.
Histological alterations in the corpus region of the stomach. (A) Representative H&E staining of a transverse section of stomach from mice at one year of age. In WT mice, progenitor cells are located in the isthmus (asterisk), PCs (basic staining) stain magenta with H&E and are located in the neck (black arrow). ECL cells and zymogenic cells (acid staining) stain dark purple with H&E and are located at the base of oxyntic glands (gray arrow). In KI/KI mice, cellular disorganization and increased thickness of the stomach wall were observed, characterized by the presence of proliferating cells (at isthmus in WT mice) and ECL-cells (at base in WT mice) within the neck region of gastric corpus glands (asterisk). In addition, high numbers of epidermoid cysts surrounded by a single layer of cuboidal epithelium (gray arrowhead), vacuolization of gastric mucosal cells (white arrow) and widely opened lumen of the oxyntic glands (white arrowhead) were seen in KI/KI mice. In the enlarged image at the far right, increased number of grouped cells from the isthmus region (black arrowhead), dysplastic cytoplasms of PCs (black arrow) and hyalinosis (light gray arrow), indicating a premalignant condition, are shown. (B) IHC of gastric corpus stained with anti-Ki67 antibody. In WT mice, the staining is limited to the isthmus region, which is the proliferative zone. Increased Ki67 staining is observed in the KI/KI stomach isthmus, but is also seen in the neck region (black arrow). (C) IHC of gastric corpus stained with anti-chromogranin A antibody. In WT mice, the staining is limited to the base of the oxyntic glands whereas in KI/KI stomachs it is also seen in the entire neck region (black arrows). (D) Alcian Blue-PAS staining of the corpus region of the stomach of WT (left) and KI/KI (right) mice. White arrows show areas of glandular metaplasia in the KI/KI stomach.
- Fig. 3.
Hypoacidity, anemia and hypergastrinemia in KI/KI mice. (A) Gastric pH values determined by direct measurement with colorimetric paper at necropsy. Measurements of two different animals are shown for each genotype; gastric pH values were ∼1, ∼4 and ∼7 for WT, KI/+ and KI/KI mice, respectively. (B) Ferritin concentrations in plasma (mM) of WT, KI/+ and KI/KI male (left) and female (right) mice. (C) Gastrin concentrations in serum (pM) of WT, KI/+ and KI/KI mice at ages indicated. (D) Representative IHC images of the antrum region of the stomach stained with anti-gastrin antibody in WT and KI/KI mice at 350 days of age. In both genotypes, the anti-gastrin antibody labels G-cells at the base of pyloric glands (black arrows). (E) IHC with anti-Ki67 antibody of the gastric antrum from representative WT and KI/KI mice. In both genotypes, progenitor cells are located at the base of pyloric glands (asterisks). (F) Gastrin concentrations in serum (pM) of WT, KI/+ and KI/KI mice. n=6 per genotype. ns, not significant. Data in B,C,F are represented as mean±s.d.
- Fig. 4.
Phenotype prevention by treatment with HCl water. (A) Representative macroscopic external (left) and internal (right) images of stomachs are shown for HCl water-treated and untreated WT and KI/KI mice at >350 days of age. No lesions or injuries were observed in WT mice following this treatment. Gastric hyperplasia in treated KI/KI mice (pH 4) is drastically reduced compared with KI/KI mice without treatment (pH 7). Scale bar: 1 cm. (B) Representative H&E staining images of KI/KI stomachs from treated mice compared with WT and non-treated KI/KI mice at 350 days of age. Similar architecture consisting of progenitor neck mucosa cells located in the isthmus (asterisks), PCs in the neck (black arrows), and ECL and zymogenic cells in the base of oxyntic glands (dark gray arrows) were observed in WT and treated KI/KI stomachs. Widely opened oxyntic glands (white arrowhead), grouped nuclei from the isthmus region (black arrowhead) and hyalinosis (light gray arrow), observed in untreated KI/KI stomachs, were not detected in treated mice. (C) Serum gastrin concentrations (pM) in WT, KI/+ and KI/KI mice treated for the times indicated. (D) Ferritin concentrations in plasma (µM) of treated WT, KI/+ and KI/KI males (top) and females (borrom). (E) IHC of corpus region of a representative treated KI/KI stomach with anti-Ki67 (left) and anti-chromogranin A (right) antibodies. Staining is limited to the isthmus and the base of the oxyntic glands, respectively, as observed in WT mice (Fig. 2B). (F) Alcian Blue-PAS staining of the corpus region of a representative KI/KI stomach from a 350-day-old mouse. n=6 per genotype. ns, not significant. Data in C,D are represented as mean±s.d.
- Fig. 5.
Phenotype reversion by treatment with HCl water. (A) Representative macroscopic external (left) and internal (right) images of stomachs are shown for KI/KI mice after 150 days of treatment starting at 150 or 250 days of age. Gastric hyperplasia in KI/KI mice treated (pH 4) from day 150 was drastically reduced compared with untreated KI/KI mice (pH 7). The extent of gastric hyperplasia reduction was less evident in mice that started treatment at 250 days of age. See Table 1 for gastric thickness data. Scale bar: 1 cm. (B) Corpus region of a stomach from a KI/KI mouse treated for 150 days starting at 150 days of age stained with H&E. Cellular organization was partially restored in treated mice. Major lesions also disappeared in these mice compared with KI/KI mice without treatment. In treated KI/KI stomachs, progenitor neck mucosa cells were located in the isthmus (black asterisk), PCs in the neck (black arrow), and ECL and zymogenic cells at the base of oxyntic glands (dark gray arrow). Widely opened oxyntic glands (white arrowhead), grouped nuclei from the isthmus region (black arrowhead) and hyalinosis (light gray arrow), observed in KI/KI stomachs, were not observed in treated KI/KI stomachs. (C) Serum gastrin concentrations (pM) in WT and KI/KI mice treated for 80 and 150 days of treatment. (D) Ferritin concentrations in plasma (µM) for male and female mice after 150 days of treatment. (E) IHC staining with anti-chromogranin A antibody of the corpus region of a representative KI/KI stomach after 150 days of treatment. (F) Alcian Blue-PAS staining of the corpus region of a representative KI/KI stomach after 150 days of treatment. n=6 per genotype. ns, not significant. Data in C,D are represented as mean±s.d.
Article navigation
Related articles
Cited by...
More in this TOC section
Similar articles
Subject collections
Other journals from The Company of Biologists
DMM and COVID-19
We are aware that the COVID-19 pandemic is having an unprecedented impact on researchers worldwide. The Editors of all The Company of Biologists’ journals have been considering ways in which we can alleviate concerns that members of our community may have around publishing activities during this time. Read about the actions we are taking at this time.
Please don’t hesitate to contact the Editorial Office if you have any questions or concerns.
Professor Elizabeth Patton appointed as DMM’s next Editor-in-Chief
We are pleased to announce that The Company of Biologists directors have appointed Professor Elizabeth Patton as DMM's new Editor-in-Chief. As Paresh Vyas writes in his Editorial, Liz ‘brings vitality and a passion for the remit of DMM, and is deeply embedded in the community.’
Did you know DMM Conference Travel Grants can be used for online meetings?
With travel restrictions still in place, we want to continue supporting early-career researchers in their careers. DMM’s Conference Travel Grants can now be used to attend virtual and online scientific meetings, workshops, conferences and training courses.
The current application round closes on 8 February 2021 – find out more.
Identification of MYOM2 as a candidate gene in hypertrophic cardiomyopathy and Tetralogy of Fallot, and its functional evaluation in the Drosophila heart
Research from Silke Sperling and colleagues uses Drosophila to identify MYOM2 as a candidate gene in congenital heart malformations in this issue’s Editor’s choice.
C. elegans as a disease model
A new Research article from Doyle et al., models spinal muscular atrophy in C. elegans to show that that targeting therapies to muscle cells is more effective than neuronal delivery. Find more research using C. elegans as a disease model in our latest subject collection.
Call for papers – The RAS Pathway: Diseases, Therapeutics and Beyond
Our upcoming special issue is now welcoming submissions until 1 April 2021. Guest-edited by Donita Brady (Perelman School of Medicine at the University of Pennsylvania, USA) and Arvin Dar (Icahn School of Medicine at Mount Sinai, USA), the issue will focus on the targeting the RAS pathway. Find out more about the issue and how to submit your manuscript.
Interview – Kim Landry-Truchon and Nicolas Houde
In an interview, first authors Kim Landry-Truchon and Nicolas Houde discuss their mouse model of the early stages of pleuropulmonary blastoma, reflecting on the implications of their work and the future of their field.